Nippon Chemiphar Co., Ltd.

¥1,463As of Sun 8 Nov 2026, 12:00 UTC
TSE:4539Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (7.99%)
Div yield 3.42%
ROE (2.52%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.19
PE TTM —
TSR TTM (9.46%)
Mkt cap ¥5.301B
ROIC (2.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,781
21.75%
25.23%
Hold 11|5|1|11|7
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
16.89
18.10
19.24
20.20
10.95%
23.23%
22.74%
15.18%
Revenue¥M
284.5
299.0
316.4
321.1
10.97%
10.94%
14.37%
17.00%
Peers (US$33.66M)
Cap (US$)
PE
16.89M
—
Capital
TTM
5Y
10Y
Leveragex
1.149
(4.524)
(3.558)
EBIT/Intx
8.566
0.268
0.250
Own earn%
(39.34)
(97.44)
(90.38)
Sh yield%
26.51
19.06
20.71
Owners
Insiders/Inst%
9.51
22.52
Short interest%
1.47
SBC / revenue%
4.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
19–26
$1 testx
0.0
Incr. ROIC%
2